An investigation of the main mutagenic components of a carcinogenic oil by fractionation and testing in the modified Ames assay

The toxic effects of spent crankcase oil exposures; systematic review and meta-analysis

The study sought to execute a systematic review and meta-analysis to describe the toxicological implications associated with exposures of humans and laboratory animals to Spent Crankcase Oil (SCO). Databases like PubMed, Scopus, Science Direct, Google Scholar, Web of Science, and PlosOne were searched systematically for all data that assessed the effects of SCO on humans and animals. For each parameter involved in the meta-analysis (those with extractable data), mean, standard deviation, the sample size was extracted for both exposure groups and control. This was then used to compute the standardized mean difference (SMD). Statistical analysis and forest plots were done with RevMan 5.3 software. Twenty-eight (28) studies fulfilled the pre-specified criteria for eligibility. Fourteen (14) of the studies were used for the meta-analysis, which included a total of 1243 subjects from different human epidemiological occupational exposure studies and animal experimental studies. The meta-analysis revealed that SCO exposure caused a significant reduction in the body weight of animals (n = 5, SMD; - 1.2; 95% CI; (- 1.78, - 0.67), p = 0.0001, I² = 22%), and in the red blood cell count (n = 5, SMD; - 1.28; 95% CI; (- 2.18, - 0.38, p = 0.02); I² = 78%) and haemoglobin (n = 4, SMD; - 1.12, 95% CI; (- 2.71, 0.46); p = 0.16; I² = 89%) in animal models. While there was a significant elevation of the aspartate amino transferase (AST) (n = 6, SMD; 0.76; 95%CI; (0.41, 1.11), p = 0.0001, I² = 89%), alkaline phosphatase (ALP) (n = 5, SMD; 1.92; 95% CI; (0.02, 3.83), p = 0.05, I² = 92%), and creatinine (n = 4, SMD = 1.56; 95% CI; (0.05, 3.07), p = 0.04, I² = 90%) concentrations in comparison to the control. On the other hand, there was a non-significant effect on the alanine amino transferase (ALT) (n = 5, SMD; 1.13; 95% CI; (- 0.37, 2.62); p = 0.14; I² = 92%), urea (n = 4, SMD; 1.23; 95% CI; (- 1.18, 3.65), p = 0.32, I² = 94%), packed cell volume (PCV) (n = 5, SMD; 0.10; 95% CI; (- 0.36, 0.56), p = 0.67; I² = 47%); and the haemoglobin (n = 6; SMD; - 0.74; 95% CI; (- 1.73, 0.26), p = 0.15; I² = 89%) concentrations. Oxidative stress, heavy metals bioaccumulation, immunotoxic, genotoxic, and carcinogenic effects were also in the list of findings. The toxicological implications associated with SCO exposure points to the need for immediate establishment of policies that regulate the disposal of spent crankcase oil in the environment.

Supplementary Information

The online version contains supplementary material available at 10.1007/s43188-021-00093-2.

Mineral oil in food, cosmetic products, and in products regulated by other legislations

For a few years, mineral oils and their potential adverse health effects have been a constant issue of concern in many regulatory areas such as food, cosmetics, other consumer products, and industrial chemicals. Analytically, two fractions can be distinguished: mineral oil saturated hydrocarbons (MOSH) and mineral oil aromatic hydrocarbons (MOAH). This paper aims at assessing the bioaccumulative potential and associated histopathological effects of MOSH as well as the carcinogenic potential of MOAH for consumer-relevant mineral oils. It also covers the absorption, distribution, metabolism, and excretion of MOSH and MOAH upon oral and dermal exposures. The use and occurrence of consumer-relevant, highly refined mineral oils in food, cosmetics and medicinal products are summarized, and estimates for the exposure of consumers are provided. Also addressed are the challenges in characterizing the substance identity of mineral oil products under REACH. Evidence from more recent autopsy and biopsy studies, along with information on decreasing food contamination levels, indicates a low risk for adverse hepatic lesions that may arise from the retention of MOSH in the liver. With respect to MOAH, at present there is no indication of any carcinogenic effects in animals dermally or orally exposed to highly refined mineral oils and waxes. Such products are used not only in cosmetics but also in medicinal products and as additives in food contact materials. The safety of these mineral oil-containing products is thus indirectly documented by their prevalent and long-term use, with a simultaneous lack of clinical and epidemiological evidence for adverse health effects.

DNA adducts produced by oils, oil fractions and polycyclic aromatic hydrocarbons in relation to repair processes and skin carcinogenesis

Ten polycyclic aromatic hydrocarbons (PAHs) mainly with three or four aromatic rings were tested for their ability to induce DNA adduct formation in mouse skin. Four of these were selected to investigate adduct formation and loss over a period of 8 days. Three mineral oils were also examined for their adduct forming ability and one was selected for adduct formation and loss over a period of 8 days. In addition, fractions derived from the same oil containing 2-3- and 4-6-ring aromatic compounds were applied to mouse skin in a non-carcinogenic oil vehicle and adduct levels were observed over an 8-day period. It was found that PAHs that had no mutagenic, initiating or carcinogenic activity and those that had mutagenic activity in bacteria but no initiating activity in mouse skin failed to produce DNA adducts in mouse skin. Two of the three PAHs with initiating activity and both complete carcinogens produced clear evidence of adduct formation, the adduct levels produced by complete carcinogens being 100-1000 times greater than those produced by initiators. Examination of adduct formation and loss with the carcinogenic PAHs benzo[a]pyrene and 5-methylchrysene over an 8-day period showed a peak at 24 h and an apparent two-phase process of adduct loss. It is suggested that the first steep loss was due to DNA repair and that the more gradual subsequent loss was probably due to epidermal hyperplasia and desquamation. With the initiator 1, 4-dimethylphenanthrene (three rings) a peak of adduct formation was seen at 2 days and adduct levels were not reduced much by 8 days. This suggested that, with initiators, adduct formation and repair may be spread over a longer period than with complete carcinogens. With the whole oils, clear evidence of adduct formation was seen with both a carcinogenic non-solvent-refined oil and with a non-carcinogenic residual oil. The level of adduct formation with the residual oil, however, was much lower than with the carcinogenic oil. When adduct formation by the carcinogenic oil was examined over 8 days, the pattern of adduct formation and loss was similar to that of a tumour initiator rather than a complete carcinogen. Peak adduct levels on the diagonal of the thin-layer chromatography (TLC) plates seemed to occur at 1 and 4 days after treatment, with no clear reduction after 8 days. From examination of adducts formed by the 2-3-ring and 4-6-ring aromatic fractions, it appeared that the main adduct spots produced by the carcinogenic oil were due to the 2-3-ring aromatic components of the oil. Adduct spots near the vertical axis of the TLC plates were also seen with the 2-3-ring and 4-6-ring fractions. The relevance of these spots is uncertain, but if they truly represent adducts, the findings suggest that they are due mainly to 4-ring PAHs. The studies suggest that the activity of carcinogenic oils is largely due to substituted 3- and 4-ring polycyclic aromatic compounds and that more attention should be paid to substituted 3-ring compounds in predicting the carcinogenic potential of oils from analytical data.

DNA adduct formation by mineral oils and their fractions as indicated by 32P-postlabelling: is adduct formation truly indicative of carcinogenic potential?

Oils of differing types, physical properties and carcinogenic activity were tested for ability to produce epidermal DNA adducts 24 h after application to the skin of mice, using the 32P-postlabelling method. Two studies were carried out, the first on three oils to identify the adduct-forming components, and the second on nine oils to investigate whether the nature of the oils affected their adduct-forming potential. In addition to the whole oils, fractions of the oils containing saturated hydrocarbons, 2-6-ring aromatic compounds and polar compounds were tested in both studies in proportion to their concentration in the original oil. In addition, a further examination of the aromatic fractions from two carcinogenic oils was carried out in the first study by testing 2-3-ring and 4-6-ring subfractions (the latter containing carcinogenic polycyclic aromatic compounds (PACs)). Results from the first study indicated that carcinogenic oils do produce adducts and that the adduct-forming components were mainly in the aromatic fraction. When, however, subfractions of the aromatic fraction were examined, it was found that slightly higher adduct levels were produced by the 2-3-ring aromatic fraction than with the 4-6-ring PAC fraction. This was contrary to expectation from published work on the skin carcinogenicity of oils and suggested that some non-carcinogenic PACs may produce adducts. The second study indicated that although most carcinogenic oils produced adducts, some non-carcinogenic oils can also do so.(ABSTRACT TRUNCATED AT 250 WORDS)